Histone deacetylase inhibitor ITF2357 (givinostat) reverts transformed phenotype and counteracts stemness in in vitro and in vivo models of human glioblastoma

Overview of attention for article published in Journal of Cancer Research and Clinical Oncology, November 2018

Altmetric Badge

Mentioned by

twitter: 1 X user

Citations

dimensions_citation: 25 Dimensions

Readers on

mendeley: 38 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 1 X post from an account with 356 followers.

#newupdatesneuroonc #braintumours #neuroonc Histone deacetylase inhibitor ITF2357 (givinostat) reverts transformed phenotype and counteracts stemness in in vitro and in vivo models of human glioblastoma. - https://t.co/soY9EfArMQ

Reply Repost Favourite